Literature DB >> 12786601

Distinct regulation of cytosolic phospholipase A2 phosphorylation, translocation, proteolysis and activation by tumour necrosis factor-receptor subtypes.

Orla J Jupp1, Peter Vandenabeele, David J MacEwan.   

Abstract

The hormonally regulated Ca(2+)-dependent enzyme, cytosolic phospholipase A(2) (cPLA(2)) is activated by a range of inflammatory stimuli. Tumour necrosis factor-alpha (TNF) is one of the first known stimuli for cPLA(2) but it is not known whether both TNF receptor subtypes are involved in activating the lipase. In the present study, we show for the first time that both type I 55 kDa TNFR (TNFR1) and type II 75 kDa TNFR (TNFR2) stimulate cPLA(2) enzyme, but with distinct signalling mechanisms. TNFR1 activates mitogen-activated protein kinase (MAPK) and p38MAPK. TNFR1 then phosphorylates and activates cPLA(2) in a MAPK-dependent fashion. Furthermore, TNFR1 causes the translocation and caspase-dependent proteolysis of cPLA(2) as part of its activation profile. TNFR2, on the other hand, does not cause the phosphorylation of cPLA(2) as it does not activate MAPK or p38MAPK, but instead activates cPLA(2) by causing its translocation to plasma membrane and perinuclear subcellular regions. TNFR2 activation causes a delayed, slight increase in [Ca(2+)](i) of <50 nM that may contribute towards the translocation and activation of cPLA(2). Therefore both TNF receptor subtypes play a role in cPLA(2) activation, but by means of separate signal-transduction pathways.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12786601      PMCID: PMC1223607          DOI: 10.1042/BJ20030705

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  54 in total

1.  Tumor necrosis factor-alpha generates reactive oxygen species via a cytosolic phospholipase A2-linked cascade.

Authors:  C H Woo; Y W Eom; M H Yoo; H J You; H J Han; W K Song; Y J Yoo; J S Chun; J H Kim
Journal:  J Biol Chem       Date:  2000-10-13       Impact factor: 5.157

2.  Microdetermination of long-chain fatty acids in plasma and tissues.

Authors:  V P DOLE; H MEINERTZ
Journal:  J Biol Chem       Date:  1960-09       Impact factor: 5.157

3.  Unmodified calcium concentrations in tumour necrosis factor receptor subtype-mediated apoptotic cell death.

Authors:  S M McFarlane; H M Anderson; S J Tucker; O J Jupp; D J MacEwan
Journal:  Mol Cell Biochem       Date:  2000-08       Impact factor: 3.396

4.  MADD, a novel death domain protein that interacts with the type 1 tumor necrosis factor receptor and activates mitogen-activated protein kinase.

Authors:  A R Schievella; J H Chen; J R Graham; L L Lin
Journal:  J Biol Chem       Date:  1997-05-02       Impact factor: 5.157

5.  Arachidonic acid-selective cytosolic phospholipase A2 is crucial in the cytotoxic action of tumor necrosis factor.

Authors:  M Hayakawa; N Ishida; K Takeuchi; S Shibamoto; T Hori; N Oku; F Ito; M Tsujimoto
Journal:  J Biol Chem       Date:  1993-05-25       Impact factor: 5.157

6.  Critical duration of intracellular Ca2+ response required for continuous translocation and activation of cytosolic phospholipase A2.

Authors:  T Hirabayashi; K Kume; K Hirose; T Yokomizo; M Iino; H Itoh; T Shimizu
Journal:  J Biol Chem       Date:  1999-02-19       Impact factor: 5.157

7.  Caspase-mediated inhibition of human cytosolic phospholipase A2 during apoptosis.

Authors:  S Adam-Klages; R Schwandner; S Lüschen; S Ussat; D Kreder; M Krönke
Journal:  J Immunol       Date:  1998-11-15       Impact factor: 5.422

8.  Thrombin-induced phosphorylation and activation of Ca(2+)-sensitive cytosolic phospholipase A2 in human platelets.

Authors:  R M Kramer; E F Roberts; J V Manetta; P A Hyslop; J A Jakubowski
Journal:  J Biol Chem       Date:  1993-12-15       Impact factor: 5.157

9.  Susceptibility to TNF in the presence of inhibitors of transcription or translation is dependent on the activity of cytosolic phospholipase A2 in human melanoma tumor cells.

Authors:  C Voelkel-Johnson; T E Thorne; S M Laster
Journal:  J Immunol       Date:  1996-01-01       Impact factor: 5.422

10.  Generation and biological characterization of membrane-bound, uncleavable murine tumor necrosis factor.

Authors:  E Decoster; B Vanhaesebroeck; P Vandenabeele; J Grooten; W Fiers
Journal:  J Biol Chem       Date:  1995-08-04       Impact factor: 5.157

View more
  19 in total

Review 1.  Neuroinflammation and synaptic loss.

Authors:  Jagadeesh S Rao; Matthew Kellom; Hyung-Wook Kim; Stanley I Rapoport; Edmund A Reese
Journal:  Neurochem Res       Date:  2012-02-07       Impact factor: 3.996

2.  A ceramide analog inhibits cPLA(2) activity and consequent PGE(2) formation in LPS-stimulated macrophages.

Authors:  Meir Goldsmith; Ala Daka; Nadia F Lamour; Roi Mashiach; Yifat Glucksam; Michael M Meijler; Charles E Chalfant; Tsaffrir Zor
Journal:  Immunol Lett       Date:  2010-10-30       Impact factor: 3.685

3.  TNF-α induced apoptosis is accompanied with rapid CD30 and slower CD45 shedding from K-562 cells.

Authors:  Vladimir Jurisic; Tatjana Srdic-Rajic; Gordana Konjevic; Gordana Bogdanovic; Mija Colic
Journal:  J Membr Biol       Date:  2011-01-11       Impact factor: 1.843

4.  Nanomolar vitamin E alpha-tocotrienol inhibits glutamate-induced activation of phospholipase A2 and causes neuroprotection.

Authors:  Savita Khanna; Narasimham L Parinandi; Sainath R Kotha; Sashwati Roy; Cameron Rink; Douglas Bibus; Chandan K Sen
Journal:  J Neurochem       Date:  2009-12-17       Impact factor: 5.372

5.  Disruption of group IVA cytosolic phospholipase A(2) attenuates myocardial ischemia-reperfusion injury partly through inhibition of TNF-α-mediated pathway.

Authors:  Yukio Saito; Kazuhiro Watanabe; Daisuke Fujioka; Takamitsu Nakamura; Jun-ei Obata; Kenichi Kawabata; Yosuke Watanabe; Hideto Mishina; Shun Tamaru; Yoshihiro Kita; Takao Shimizu; Kiyotaka Kugiyama
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-03-16       Impact factor: 4.733

Review 6.  P2Y12 receptor: platelet thrombus formation and medical interventions.

Authors:  Fatemeh Moheimani; Denise E Jackson
Journal:  Int J Hematol       Date:  2012-10-01       Impact factor: 2.490

Review 7.  TNFα in myocardial ischemia/reperfusion, remodeling and heart failure.

Authors:  Petra Kleinbongard; Rainer Schulz; Gerd Heusch
Journal:  Heart Fail Rev       Date:  2011-01       Impact factor: 4.214

8.  Genome-wide association analysis of anti-TNF drug response in patients with rheumatoid arthritis.

Authors:  Maša Umiċeviċ Mirkov; Jing Cui; Sita H Vermeulen; Eli A Stahl; Erik J M Toonen; Remco R Makkinje; Annette T Lee; Tom W J Huizinga; Renee Allaart; Anne Barton; Xavier Mariette; Corinne Richard Miceli; Lindsey A Criswell; Paul P Tak; Niek de Vries; Saedis Saevarsdottir; Leonid Padyukov; S Louis Bridges; Dirk-Jan van Schaardenburg; Tim L Jansen; Ellen A J Dutmer; Mart A F J van de Laar; Pilar Barrera; Timothy R D J Radstake; Piet L C M van Riel; Hans Scheffer; Barbara Franke; Han G Brunner; Robert M Plenge; Peter K Gregersen; Henk-Jan Guchelaar; Marieke J H Coenen
Journal:  Ann Rheum Dis       Date:  2012-12-11       Impact factor: 19.103

9.  Eicosanoid release is increased by membrane destabilization and CFTR inhibition in Calu-3 cells.

Authors:  Florence Borot; Diane-Lore Vieu; Grazyna Faure; Janine Fritsch; Julien Colas; Sandra Moriceau; Maryvonne Baudouin-Legros; Franck Brouillard; Jesus Ayala-Sanmartin; Lhousseine Touqui; Marc Chanson; Aleksander Edelman; Mario Ollero
Journal:  PLoS One       Date:  2009-10-22       Impact factor: 3.240

10.  Acetate reduces PGE2 release and modulates phospholipase and cyclooxygenase levels in neuroglia stimulated with lipopolysaccharide.

Authors:  Mahmoud L Soliman; Joyce E Ohm; Thad A Rosenberger
Journal:  Lipids       Date:  2013-05-25       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.